首页> 外文OA文献 >High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time of flight mass spectrometry
【2h】

High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time of flight mass spectrometry

机译:使用一锅唾液酸的高通量量化N-聚糖 酸改性和基质辅助激光解吸电离 飞行时间质谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Appropriate glycosylation of recombinant therapeutic glycoproteins has been emphasized in biopharmaceutical industries because the carbohydrate component can affect safety, efficacy, and consistency of the glycoproteins. Reliable quantification methods are essential to ensure consistency of their products with respect to glycosylation, particularly sialylation. Mass spectrometry (MS) has become a popular tool to analyze glycan profiles and structures, showing high resolution and sensitivity with structure identification ability. However, quantification of sialylated glycans using MS is not as reliable because of the different ionization efficiency between neutral and acidic glycans. We report here that amidation in mild acidic conditions can be used to neutralize acidic N-glycans still attached to the protein. The resulting amidated N-glycans can then released from the protein using PNGase F, and labeled with permanent charges on the reducing end to avoid any modification and the formation of metal adducts during MS analysis. The N-glycan modification, digestion, and desalting steps were performed using a single-pot method that can be done in microcentrifuge tubes or 96-well microfilter plates, enabling high throughput glycan analysis. Using this method we were able to perform quantitative MALDI-TOF MS of a recombinant human glycoprotein to determine changes in fucosylation and changes in sialylation that were in very good agreement with a normal phase HPLC oligosaccharide mapping method.
机译:在生物制药工业中已经强调了重组治疗性糖蛋白的适当糖基化,因为碳水化合物成分会影响糖蛋白的安全性,功效和一致性。可靠的定量方法对于确保其产品在糖基化特别是唾液酸化方面的一致性至关重要。质谱(MS)已成为分析聚糖谱和结构的流行工具,显示出具有结构识别能力的高分辨率和灵敏度。但是,由于中性和酸性聚糖之间的电离效率不同,因此使用MS量化唾液酸化聚糖的可靠性不高。我们在此报告,在弱酸性条件下的酰胺化可用于中和仍附着在蛋白质上的酸性N-聚糖。然后可以使用PNGase F将生成的酰胺化N-聚糖从蛋白质中释放出来,并在还原端标记永久电荷,以避免在MS分析过程中发生任何修饰和金属加合物的形成。使用单罐方法进行N-聚糖修饰,消化和脱盐步骤,该方法可以在微量离心管或96孔微滤板中进行,从而可以进行高通量的聚糖分析。使用这种方法,我们能够对重组人糖蛋白进行定量MALDI-TOF MS测定,确定岩藻糖基化的变化和唾液酸化的变化,这与正相HPLC寡糖作图方法非常吻合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号